Schwenkglenks M - Search Results

1

Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons.

Blank PR, Schwenkglenks M, Szucs TD. Blank PR, et al. Among authors: schwenkglenks m. BMC Public Health. 2008 Aug 1;8:272. doi: 10.1186/1471-2458-8-272. BMC Public Health. 2008. PMID: 18673545 Free PMC article.

2

[Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].

Szucs TD, Schwenkglenks M, Rutishauser W. Szucs TD, et al. Among authors: schwenkglenks m. Med Klin (Munich). 2000 Jan 15;95(1):1-13. Med Klin (Munich). 2000. PMID: 10668338 Clinical Trial. German.

3

[Cost effectiveness of bisoprolol in treatment of heart failure in Germany. An analysis based on the CIBIS-II study].

Szucs TD, Schwenkglenks M, Paschen B, Follath F. Szucs TD, et al. Among authors: schwenkglenks m. Med Klin (Munich). 2000 Dec 15;95(12):663-71. doi: 10.1007/pl00002083. Med Klin (Munich). 2000. PMID: 11198553 Clinical Trial. German.

4

Determinants of costs and resource utilization associated with open heart surgery.

Sokolovic E, Schmidlin D, Schmid ER, Turina M, Ruef C, Schwenkglenks M, Szucs TD. Sokolovic E, et al. Among authors: schwenkglenks m. Eur Heart J. 2002 Apr;23(7):574-8. doi: 10.1053/euhj.2001.3031. Eur Heart J. 2002. PMID: 11922648 Free article.

5

The economic efficiency of amlodipine in the treatment of coronary atherosclerosis--an analysis based on the PREVENT study.

Cathomas G, Erne P, Schwenkglenks M, Szucs TD. Cathomas G, et al. Among authors: schwenkglenks m. Cardiovasc Drugs Ther. 2002 Jan;16(1):61-6. doi: 10.1023/a:1015323700206. Cardiovasc Drugs Ther. 2002. PMID: 12085980

6

Costs of asthma in a cohort of Swiss adults: associations with exacerbation status and severity.

Schwenkglenks M, Lowy A, Anderhub H, Szucs TD. Schwenkglenks M, et al. Value Health. 2003 Jan-Feb;6(1):75-83. doi: 10.1046/j.1524-4733.2003.00206.x. Value Health. 2003. PMID: 12535240 Free article.

7

[Costs and cost-effectiveness of Eptifibatide in the treatment of coronary ischemic syndromes. An analysis based on the PURSUIT study].

Szucs TD, Schwenkglenks M, Berger K, Karsch K. Szucs TD, et al. Among authors: schwenkglenks m. Z Kardiol. 2003 Mar;92(3):236-44. doi: 10.1007/s00392-003-0908-5. Z Kardiol. 2003. PMID: 12658471 Clinical Trial. German.

8

Epidemiology and costs of gastroesophageal reflux disease in Switzerland: a population-based study.

Schwenkglenks M, Marbet UA, Szucs TD. Schwenkglenks M, et al. Soz Praventivmed. 2004;49(1):51-61. doi: 10.1007/s00038-003-2090-y. Soz Praventivmed. 2004. PMID: 15040129

9

Direct medical costs of type 2 diabetes and its complications in Switzerland.

Schmitt-Koopmann I, Schwenkglenks M, Spinas GA, Szucs TD. Schmitt-Koopmann I, et al. Among authors: schwenkglenks m. Eur J Public Health. 2004 Mar;14(1):3-9. doi: 10.1093/eurpub/14.1.3. Eur J Public Health. 2004. PMID: 15080382 Free article.

10

Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001.

Sandoz MS, Ess SM, Keusch GW, Schwenkglenks M, Szucs TD. Sandoz MS, et al. Among authors: schwenkglenks m. Swiss Med Wkly. 2004 Aug 7;134(31-32):448-58. doi: 10.4414/smw.2004.10682. Swiss Med Wkly. 2004. PMID: 15389348 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters